Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study

Multiple Sclerosis : Clinical and Laboratory Research
Magnus Spangsberg BoesenMelinda Magyari

Abstract

Infections are suspected environmental triggers for multiple sclerosis (MS). The relationship between the timing and cumulative number of childhood infections regarding pediatric MS risk is uninvestigated. To investigate whether childhood infections contribute to pediatric MS. A nationwide nested case-control study with detailed MS case ascertainment including chart review was undertaken. For each MS case, we selected five control children using density sampling from the entire Danish population, matching controls to children with MS by sex and birthdate. We analyzed data with the cumulative number of childhood infections as exposure and MS as outcome. Hazard ratios (HRs) including 95% confidence intervals (CIs) were estimated using Cox regression. We identified 212 children with MS and 1,060 controls. Median age at MS onset was 15.3 years (range: 7.6-17.8 years); 72% were girls. Each infection during the preceding 3 years increased the hazard for MS by 11% (95% CI = 1.01-1.22, p = 0.04); having 5+ infections compared with 0-4 infections in the preceding 3 years doubled the hazard for MS (HR: 2.18; 95% CI = 1.12-4.30, p = 0.02). Children with MS appeared to have more infections in the 3 years preceding MS clinical onset; accord...Continue Reading

References

Jun 8, 1985·Lancet·W A SibleyK Clark
Feb 1, 1966·Journal of Neurology, Neurosurgery, and Psychiatry·U LeibowitzM Alter
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Nov 1, 1995·Progress in Neurobiology·C R Gale, C N Martyn
Nov 19, 2002·Statistics in Medicine·Elisabeth Wreford Andersen, Per Kragh Andersen
Apr 22, 2004·JAMA : the Journal of the American Medical Association·Suad AlotaibiBrenda Banwell
Sep 17, 2004·Brain : a Journal of Neurology·Peter BagerTine Westergaard
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Feb 28, 2006·Annals of Neurology·Evan L ThackerAlberto Ascherio
Apr 7, 2006·American Journal of Epidemiology·Alvaro AlonsoMiguel A Hernán
May 6, 2006·American Journal of Epidemiology·Peter BagerTine Westergaard
Jan 26, 2007·Pharmacoepidemiology and Drug Safety·Samy Suissa
Apr 11, 2009·Current Opinion in Neurology·Marco SalvettiFrancesca Aloisi
Jun 8, 2011·Neurology·E WaubantUNKNOWN US Pediatric MS Network
Aug 4, 2011·Scandinavian Journal of Public Health·Carsten Bøcker Pedersen
Aug 4, 2011·Scandinavian Journal of Public Health·Elsebeth LyngeMatejka Rebolj
Aug 4, 2011·Scandinavian Journal of Public Health·John Sahl AndersenAllan Krasnik
Sep 8, 2011·Scandinavian Journal of Public Health·Lau Caspar ThygesenHenrik Brønnum-Hansen
Sep 17, 2011·American Journal of Epidemiology·Mette NørgaardHenrik Toft Sørensen
Oct 10, 2012·Nature Reviews. Neurology·Alberto AscherioJan D Lünemann
Apr 11, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Lauren B KruppUNKNOWN International Pediatric Multiple Sclerosis Study Group
Apr 30, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tanuja Chitnis
Jun 17, 2014·The British Journal of Nutrition·Katja H MadsenRikke Andersen
Jun 6, 2015·Acta Neurologica Scandinavica·N Koch-HenriksenB Laursen
Jul 23, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Naila MakhaniUNKNOWN Canadian Pediatric Demyelinating Disease Network
Aug 13, 2015·Multiple Sclerosis and Related Disorders·Melinda MagyariPer Soelberg Sørensen
May 14, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Helen TremlettUNKNOWN US Network of Pediatric MS Centers
Sep 23, 2016·BMC Neurology·Helen TremlettUNKNOWN US Network of Pediatric MS Centers

❮ Previous
Next ❯

Citations

Aug 18, 2020·Expert Opinion on Drug Safety·Huah Shin NgHelen Tremlett
Jan 30, 2019·Frontiers in Neurology·Domenico PlantoneTatiana Koudriavtseva
Nov 17, 2020·Frontiers in Immunology·Tatiana KoudriavtsevaMatilde Inglese
Sep 9, 2021·Expert Review of Neurotherapeutics·Amin ZarghamiBruce V Taylor

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology
Peter Flachenecker, Kristin Stuke
Nihon rinsho. Japanese journal of clinical medicine
Toshiyuki FukazawaKunio Tashiro
Neurologic Clinics
Brian G Weinshenker
© 2022 Meta ULC. All rights reserved